Making essential
medicines accessible
in Israel
K.S.Kim International (Sk-Pharma) Ltd. (part of the SK Pharma Group) registers, launches, and reliably supplies prescription and OTC medicines for Israel’s HMOs and hospitals—combining regulatory excellence, market access, and nationwide distribution.
Regulatory Infrastructure for Scalable Growth
We’ve built a regulatory backbone designed to support long-term expansion. Our expertise ensures that both new assets and in-market products meet evolving requirements, keeping us agile and compliant in a dynamic regulatory landscape.
Market Access & Tender Strategy
We drive pricing, reimbursement, and national procurement strategies, supported by data-driven analysis and payer insight. Our approach ensures optimal positioning in tenders and accelerated access to medicines.
Commercial Execution & Digital Engagement
Our commercial success is driven by strong field expertise and smart digital engagement. Through scientific collaboration, targeted communication, and data-led marketing, we build lasting connections with healthcare professionals across every therapeutic area.
Distribution & Supply Continuity
We manage fully compliant, nationwide distribution channels to ensure uninterrupted availability. AI-supported forecasting models strengthen supply resilience and readiness for both new launches and routine stock management.
TRUST & COMPLIANCE
+
GMP-Certified Quality System
Our operations meet the highest regulatory standards, certified by Israel’s Ministry of Health for Good Manufacturing Practices (GMP).
+
Pharmacovigilance & QA Frameworks
We maintain robust pharmacovigilance and quality assurance infrastructures that support safety, compliance, and long-term product stewardship.
+
Exclusive Manufacturer Partnerships
We hold over 40 exclusive agreements with global manufacturers, ensuring a differentiated and stable portfolio tailored to Israel’s healthcare market.
+
Nationwide Distribution Infrastructure
Our national distribution network ensures seamless coverage across hospital, HMO, and retail channels, backed by stringent regulatory compliance.
+
Deep Tender & Procurement Expertise
Our track record in government tenders and institutional procurement positions us as a trusted partner in securing sustainable market access.
+
Enhanced Digital Engagement Strategies
Our commercial approach is supported by enhanced digital engagement strategies, enabling consistent and targeted communication with healthcare professionals and reinforcing our position across therapeutic channels.
Media
Latest updates on registrations, tenders, launches, and partnerships from K.S.Kim International (Sk-Pharma) Ltd. and SK Pharma.
Products
Our portfolio spans hospital critical injectables, specialty therapies, and community care products. K.S.Kim International (Sk-Pharma) Ltd. holds 40+ exclusive agreements with leading manufacturers, and most launches are under our private label, ensuring consistent quality and availability for Israel’s HMOs and hospitals.
Customers & Partners
We collaborate across the healthcare value chain—from HMO frameworks and hospital pharmacies to national procurement bodies, distribution networks, and industry partners—to enable rapid, compliant market entry and reliable, sustained access nationwide.
Partner with K.S. Kim International (Sk-Pharma) Ltd.
We support stakeholders across the healthcare value chain
send us your request and we’ll follow up.
send us your request and we’ll follow up.
- Registration & regulatory strategy
- Market access, pricing, and tender support
- Commercialization with hospital & retail field teams
- Reliable, compliant distribution & supply continuity